Skip to content
wua. France
English

Paul-Brousse Hospital opens a new way to test drugs on livers removed during transplants

AI-generated editorial illustration; this is not a photograph of the event.
Produced by wua.life

Paul-Brousse Hospital in Villejuif inaugurated a machine on 17 November that keeps diseased livers functioning after they are removed during transplants. Doctors say they can use it to compare how cancerous and healthy tissue in the same liver respond to a drug and observe the organ by ultrasound. Public hospital researchers will be able to use the livers free of charge, while private pharmaceutical labs will pay, franceinfo reported on 18 November.

The organ kept for research is the transplant recipient’s old liver, not the donor liver. In a room between operating theatres, it rests in an open vessel. The machine circulates blood and supplies oxygen. A dialysis system takes on a filtering role normally performed by the kidneys, while a separate control regulates blood sugar. Professor Éric Vibert said the team aims to keep the liver functioning for at least a week.

The open vessel matters because doctors can reach the tissue they want to study. As Dr Élie Farah explained to franceinfo, a researcher can inject a drug into a cancerous area and into healthy tissue in the same organ. That lets the team study a human liver’s response without giving the drug to the patient at this stage. Whether the treatment benefits a patient is a separate clinical question.

Sources

Independent editorial content. WUA is not affiliated with any political party. 2026-11-18